ICAM1 and neoplasm: We propose that CXCR3highCD8+ T in healthy volunteers exhibited anti-tumor capacity by CXCL10/CXCR3-activated LFA-1-ICAM-1 interaction and resulted in consequent CD8+ T cell activation (Fig. 7A).